Medical release archive

New data show benefit of Tagrisso in patients with EGFR-mutated non-small cell lung cancer and central nervous system metastases

New England Journal of Medicine publishes results of Phase III FLAURA trial in the 1st-line treatment of EGFR-mutated non-small cell lung cancer

Faslodex (fulvestrant) receives EU approval for the treatment of hormone receptor-positive advanced breast cancer in combination with palbociclib

ZS-9 (sodium zirconium cyclosilicate) Phase III long-term safety and efficacy data presented at ASN Kidney Week 2017

AstraZeneca and Chi-Med’s savolitinib shows encouraging clinical activity in EGFR mutation-positive lung cancer with MET-amplification

Forxiga DEPICT-1 trial demonstrates improved glycaemic control without increasing hypoglycaemia, lowered weight and total daily insulin dose in patients with type-1 diabetes

AstraZeneca presents new evidence on Symbicort (budesonide/formoterol) in COPD patients at risk of exacerbation

New data supports long-term efficacy of ticagrelor in patients up to five years following a heart attack

AstraZeneca presents Tagrisso (osimertinib) data in patients with EGFR T790M-mutation positive lung cancer and central nervous system metastases

Lynparza (olaparib) maintenance treatment offers sustained quality of life alongside improved progression-free survival in women with BRCA-mutated ovarian cancer